Anacor Pharmaceuticals, Inc. (ANAC) Secures $45 Million Loan Facility
6/12/2013 10:06:52 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Announces Successful Completion of Pre-NDA Communications With the FDA for Tavaborole
5/29/2013 10:18:25 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) to Present at Deutsche Bank (DB)'s 38th Annual Healthcare Conference
5/24/2013 6:31:29 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Reports First Quarter 2013 Financial Results
5/10/2013 7:40:56 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Announces First Quarter 2013 Financial Results Conference Call and Webcast
5/8/2013 7:45:47 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Prices $20 Million Public Offering of Common Stock
4/26/2013 10:01:22 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Signs $17.7 Million Research Agreement With the Bill & Melinda Gates Foundation
4/8/2013 9:00:43 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) to Hold Conference Call Tomorrow, March 21, 2013 at 8am ET / 5am PT to Discuss Preliminary Results From the Phase 2 Dose-Ranging Study of AN2728 in the Treatment of Adolescents With Atopic Dermatitis
3/21/2013 11:23:02 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Reports 2012 Fourth Quarter and Year-End Financial Results
3/15/2013 6:24:38 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Reveals Positive Data From Second Phase-3 Trial of Tavaborole
3/1/2013 7:06:25 AM
More...
|
|